Your browser doesn't support javascript.
loading
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
Timmers, Maarten; Tesseur, Ina; Bogert, Jennifer; Zetterberg, Henrik; Blennow, Kaj; Börjesson-Hanson, Anne; Baquero, Miquel; Boada, Mercè; Randolph, Christopher; Tritsmans, Luc; Van Nueten, Luc; Engelborghs, Sebastiaan; Streffer, Johannes Rolf.
Afiliação
  • Timmers M; Janssen Research and Development, A Division of Janssen Pharmaceutica N.V., Beerse, Belgium; Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. Electronic address: mtimmer3@its.jnj.com.
  • Tesseur I; Janssen Research and Development, A Division of Janssen Pharmaceutica N.V., Beerse, Belgium.
  • Bogert J; Janssen Research and Development LLC, Raritan, NJ, USA.
  • Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistery Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institu
  • Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistery Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Börjesson-Hanson A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Sahlgrenska University Hospital, Mölndal, Sweden; Clinical Trials, Theme Aging, Karolinska University Hospital, Stockholm, Sweden.
  • Baquero M; Neurology Department, Hospital Universitari I Politecnic La Fe, Valencia, Spain.
  • Boada M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya-Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Randolph C; MedAvante-ProPhase, Hamilton, NJ, USA; Department of Neurology, Loyola University Medical Center, Maywood, IL, USA.
  • Tritsmans L; Janssen Research and Development, A Division of Janssen Pharmaceutica N.V., Beerse, Belgium.
  • Van Nueten L; Janssen Research and Development, A Division of Janssen Pharmaceutica N.V., Beerse, Belgium.
  • Engelborghs S; Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; Department of Neurology and Center for Neurosciences, UZ Brussel and Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Streffer JR; Janssen Research and Development, A Division of Janssen Pharmaceutica N.V., Beerse, Belgium; Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Neurobiol Aging ; 79: 131-141, 2019 07.
Article em En | MEDLINE | ID: mdl-31055223

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeos beta-Amiloides / Proteínas tau / Cognição / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurobiol Aging Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeos beta-Amiloides / Proteínas tau / Cognição / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurobiol Aging Ano de publicação: 2019 Tipo de documento: Article